Soligenix
SNGX
#10223
Rank
NZ$28.1 M
Marketcap
NZ$2.79
Share price
-1.23%
Change (1 day)
-48.77%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.66 Million

According to Soligenix's latest financial reports the company's total debt is NZ$0.66 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$2.63 M-52.36%
2023-12-31NZ$5.52 M-65.74%
2022-12-31NZ$16.12 M10.58%
2021-12-31NZ$14.58 M0.17%
2020-12-31NZ$14.56 M7607.93%
2019-12-31NZ$0.18 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31NZ$0.42 M-91.16%
2014-12-31NZ$4.83 M-52.01%
2013-12-31NZ$10.07 M
2004-12-31NZ$0.16 M-70.58%
2003-12-31NZ$0.55 M-60.4%
2002-12-31NZ$1.39 M167.1%
2001-12-31NZ$0.52 M-28.34%
2000-12-31NZ$0.72 M-2.9%
1999-12-31NZ$0.75 M-1.11%
1998-12-31NZ$0.75 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.14 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$44.19 B 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$105.32 B 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.27 B 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$32.15 M 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.55 B 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel